U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Cabergoline

An ergoline derivative and dopamine D2-agonist that inhibits PROLACTIN secretion. It is used in the management of HYPERPROLACTINEMIA, and to suppress lactation following childbirth for medical reasons. Cabergoline is also used in the management of PARKINSON DISEASE.

Year introduced: 2019 (1985)

PubMed search builder options

Subheadings:

Tree Number(s): D03.132.327.287.131, D03.633.400.439.197

MeSH Unique ID: D000077465

Registry Number: LL60K9J05T

Entry Terms:

  • 1-((6-allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea
  • FCE 21336
  • FCE-21336
  • Galastop
  • Cabaser
  • Cabergoline Diphosphate
  • 1-Ethyl-2-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta-carbonyl)urea diphosphate
  • Cabaseril
  • Dostinex

Pharmacologic Action:

Supplemental Content

Loading ...